Australia for Early Phase Clinical Development

Australia for Early Phase Clinical Development

05-16-2018 12:00 pm - 05-16-2018 2:00 pm


Novotech and CoSec will be onsite to discuss the advantageous Australian regulatory landscape for early phase clinical development. Fast regulatory timelines and the 43.5% research and development Tax Rebate make Australia an ideal destination for small biotech companies entering clinical trials.

Alex Ireland, MPH

Business Development Associate

Alex Ireland has been working in the biotech industry for the past five years from sales to operations, and has been working for Novotech for the past year. She is passionate about working with small-biotech companies and educating them on the benefits of running clinical trials in the Asia Pacific. Born and raised in the Bay Area, she earned a Master’s Degree from Boston Pharmaceuticals in Epidemiology and International Health.

Upcoming Event

  • San Carlos Open House

    Come to meet MBC BioLabs residents, tour our new space in San Carlos, and hear about our exciting plans for the future. There will be posters from our companies, a live band, and an opportunity to chat with our partners and staff. RSVP In just 4 years, we have helped 116 entrepreneurial teams create fast, focused and frugal biotech companies that have gone on to raise $2.4 billion and counting. With this new facility, we can empower more entrepreneurs with the space and resources they need to tackle world changing science. Come join us in celebrating our newest MBC Biolabs campus and welcome our residents and partners!


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter